Alzheimer's Disease Trial, Recruiting (NCT06230783)

Alzheimer's Disease Trial, Recruiting NCT06230783 Sponsor: University of Wisconsin, Madison Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06230783 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are already enrolled in specific Wisconsin-based Alzheimer's research programs (the Wisconsin Alzheimer's Disease Research Center Clinical Core, IMPACT studies, or the Wisconsin Registry for Alzheimer's Prevention)
People whose thinking and memory are either normal or only mildly affected (a condition called Mild Cognitive Impairment)
People between the ages of 40 and 80 years old
People who have had a study visit through one of those Wisconsin research programs within the past 12 months or have one coming up in the next 12 months
People who have already provided a blood plasma sample to one of those Wisconsin research programs for Alzheimer's-related testing

Who may not be able to join:

People who are not currently active members of the Wisconsin Alzheimer's Disease Research Center or Wisconsin Registry for Alzheimer's Prevention programs
People who have been diagnosed with dementia
People who are unable or unwilling to give their informed consent to participate
People who have been diagnosed with a significant neurological condition (confirm with trial site for specific conditions this covers)
People who have a speech disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kimberly D Mueller, PhD, CCC-SLP, University of Wisconsin, Madison

Phone: 608-264-1019

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06230783

Sponsor: University of Wisconsin, Madison

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 608-264-1019

More information: https://clinicaltrials.gov/study/NCT06230783

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are already enrolled in specific Wisconsin-based Alzheimer's research programs (the Wisconsin Alzheimer's Disease Research Center Clinical Core, IMPACT studies, or the Wisconsin Registry for Alzheimer's Prevention)
People whose thinking and memory are either normal or only mildly affected (a condition called Mild Cognitive Impairment)
People between the ages of 40 and 80 years old
People who have had a study visit through one of those Wisconsin research programs within the past 12 months or have one coming up in the next 12 months
People who have already provided a blood plasma sample to one of those Wisconsin research programs for Alzheimer's-related testing

Who may not be able to join:

People who are not currently active members of the Wisconsin Alzheimer's Disease Research Center or Wisconsin Registry for Alzheimer's Prevention programs
People who have been diagnosed with dementia
People who are unable or unwilling to give their informed consent to participate
People who have been diagnosed with a significant neurological condition (confirm with trial site for specific conditions this covers)
People who have a speech disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Wisconsin, Madison

Registry

ClinicalTrials.gov

Start date

22 January 2025

Est. completion

1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Usability of remote at-home speech collection - objective; Usability of remote at-home speech collection - objective; Feasibility of remote at-home speech collection; Feasibility of remote at-home speech collection; Feasibility of remote at-home speech collection; Usability of remote at-home speech collection - subjective

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov